Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells.
about
Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral BloodCirculating tumors cells as biomarkers: progress toward biomarker qualificationNanotheranostics of circulating tumor cells, infections and other pathological features in vivoCirculating Tumor Cells in Early-Stage Breast Cancer.Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients.CTC-mRNA (AR-V7) Analysis from Blood Samples-Impact of Blood Collection Tube and Storage Time.A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells.CTC enumeration and characterization: moving toward personalized medicine.Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patientsStabilization of circulating tumor cells in blood using a collection device with a preservative reagent.Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer.Molecular profiling of individual tumor cells by hyperspectral microscopic imagingMethylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.Assays for pharmacodynamic analysis of histone deacetylase inhibitors.Detecting circulating tumor cells: current challenges and new trends.Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patientsThe presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patientsMorphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells.Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic TreatmentEvaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancerDetection of the circulating tumor cells in cancer patients.Circulating tumor cells as emerging tumor biomarkers in breast cancer.Clinical implications of the detection of circulating tumor cells in breast cancer patients.Diagnostic significance of allelic imbalance in cancer.The role and clinical relevance of disseminated tumor cells in breast cancer.Nanotechnology applications in diagnosis and treatment of metastasis.Separation and detection of rare cells in a microfluidic disk via negative selection.Detection of circulating tumor cells: Clinical relevance of a novel metastatic tumor marker.Evaluation of Circulating Endometrial Cells as a Biomarker for Endometriosis.A comparative performance analysis of total PSA, percentage free PSA, PSA velocity, and PSA density versus the detection of primary circulating prostate cells in predicting initial prostate biopsy findings in Chilean men.Detection of circulating tumour cells with the CellSearch system in patients with advanced-stage head and neck cancer: preliminary results.Detection of circulating tumor cells in liquid biopsy from Ewing sarcoma patients.Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer.Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.Significance of apoptotic and non-apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancer.Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome.Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study.
P2860
Q24597444-3B44DB85-B5A3-4434-92C9-04486C87D869Q26852579-33355970-B0BF-40B3-A577-54881C73961AQ30442087-FFD38C89-3DEA-44B5-BEA1-F12E7C5F2612Q33579111-688E4507-6A28-45B6-AA14-83153A9EC992Q33746929-2C4EA508-B0AE-4315-A68F-3965A3CE2553Q33755286-CAD9B3CD-FCD8-40B9-9C3B-51EE8D8C1F78Q34289862-68AEAACA-83DE-4012-B0F5-9B7C32FF065EQ34396921-CC7D7E3D-794E-4BA5-AFC5-64D41B0B528BQ34577724-13839793-D4A0-487A-8788-33872B688BC5Q34994963-89470D17-59B8-4C04-BDBF-336C426B69DDQ35112470-D69B1193-90A7-4E5C-8E87-5420BF14CD39Q35558093-3300CCA5-49BE-4707-A946-724B4477DCCDQ35605856-70812501-2644-41E2-9FCC-A7C00B08E9A9Q35913941-EC1D2471-8186-4681-A758-F534AD40D029Q35958967-26BAA49E-F710-47D4-84AE-58E80372F0C1Q36546255-6917B8B0-D3FC-4A0F-8435-20A16132C2B8Q36915318-800151F5-E34E-43B6-BBCE-A3BE82B47739Q36955133-CCBDCE85-9882-437C-B771-46E3153370FDQ37038658-F32FE3C4-81DD-489C-A92A-046A2BFFB7E8Q37177902-44666A9D-F239-4AC0-B168-EBDD8EDC2C68Q37453217-8A961356-FF77-4293-AD05-5D0B956CC3E4Q37693477-B37C0DF6-6D0A-4351-85C9-9C41A9C79B2FQ37719099-28B89524-3861-42B7-A0B0-9BC1422EB289Q37818289-CAA2C6CD-672F-416E-9031-9C783F3E5E3BQ37908134-22F0076D-8AB5-40EB-89AF-2A7878B703ABQ37980500-D01FD142-2371-43FE-8EB7-062B8414481AQ38089241-EA1DE23C-6101-454B-A6FF-C8586A940177Q38179204-25B01A82-8551-4340-8F60-FE4DB38985BEQ38254086-ABE38917-92AF-4BA8-956E-0F62C7461200Q39630236-BBA0926A-DCE0-40C1-9BE0-90D7E4A15BD3Q42242553-3B95E3FE-A7EB-4A16-B176-52933715F01DQ42267344-4B276855-E406-45AA-803C-E268FE64116AQ42738041-C796516F-85AA-4983-A23D-CDF0999C6A27Q44137911-BE5829F0-671C-4C73-90F3-214C660D8CCBQ48501750-B614EA58-F2CC-48BA-B7B3-205895745717Q50317499-6FA9E03F-A5EC-4BC3-A175-1CAA7B1EFABCQ50785106-0B366101-D673-4E06-8540-DA5669A53A18Q53638673-7A0C9510-C037-443B-A6FE-22BE31C7F274Q54446497-21B127D0-7D7F-4DFE-9948-97B12EA9C79AQ54526390-2572E653-9F49-49B0-9658-9830D9B20F01
P2860
Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Methods for isolating circulat ...... sification as carcinoma cells.
@ast
Methods for isolating circulat ...... sification as carcinoma cells.
@en
type
label
Methods for isolating circulat ...... sification as carcinoma cells.
@ast
Methods for isolating circulat ...... sification as carcinoma cells.
@en
prefLabel
Methods for isolating circulat ...... sification as carcinoma cells.
@ast
Methods for isolating circulat ...... sification as carcinoma cells.
@en
P2093
P1433
P1476
Methods for isolating circulat ...... sification as carcinoma cells.
@en
P2093
Solomayer EF
P304
P356
10.1080/14653240510027082
P577
2005-01-01T00:00:00Z